Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-16 Purchase |
2020-12-17 2:43 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner |
10,937,500 | $3.2 | $35,000,000 | 71,178,364 (Indirect) |
View |
| 2020-12-16 Purchase |
2020-12-17 2:39 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner |
10,937,500 | $3.2 | $35,000,000 | 71,178,364 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-01-11 5:38 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus Partners LLC Director 10% Owner |
0 | $0 | 4,321,214 (Direct) |
View |
| 2020-12-31 Other |
2021-01-05 9:21 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus C.V. Director 10% Owner |
4,321,214 | $0 | 4,321,214 (Direct) |
View |